Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises

L Rezakhani, AF Kelishadrokhi… - Chemistry and physics …, 2021 - Elsevier
There are no commercially available effective antiviral medications or vaccines to deal with
novel coronavirus disease (COVID-19). Hence there is a substantial unmet medical need for …

[HTML][HTML] Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19

S Yasamineh, HG Kalajahi, P Yasamineh… - Stem Cell Research & …, 2022 - Springer
The SARS-COV-2 virus has infected the world at a very high rate by causing COVID-19
disease. Nearly 507 million individuals have been infected with this virus, with …

[HTML][HTML] MSC therapies for COVID-19: importance of patient coagulopathy, thromboprophylaxis, cell product quality and mode of delivery for treatment safety and …

G Moll, N Drzeniek, J Kamhieh-Milz, S Geissler… - Frontiers in …, 2020 - frontiersin.org
Numerous clinical trials of mesenchymal stromal/stem cells (MSCs) as a new treatment for
coronavirus-induced disease (COVID-19) have been registered recently, most of them …

Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: an …

X Xu, W Jiang, L Chen, Z Xu, Q Zhang… - Clinical and …, 2021 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) was identified in December 2019 and has …

[HTML][HTML] The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm

M Kavianpour, M Saleh, J Verdi - Stem Cell Research & Therapy, 2020 - Springer
The outbreak of coronavirus disease 2019 (COVID-19) pandemic is quickly spreading all
over the world. This virus, which is called SARS-CoV-2, has infected tens of thousands of …

Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm

N Song, H Wakimoto, F Rossignoli, D Bhere… - Stem Cells, 2021 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has grown to be a global
public health crisis with no safe and effective treatments available yet. Recent findings …

Transmission patterns of COVID-19 in the mainland of China and the efficacy of different control strategies: a data-and model-driven study

J Zu, ML Li, ZF Li, MW Shen, YN Xiao… - Infectious diseases of …, 2020 - mednexus.org
Background: The coronavirus disease 2019 (COVID-19) outbreak has seriously endangered
the health and lives of Chinese people. In this study, we predicted the COVID-19 epidemic …

[HTML][HTML] Extracellular vesicles as a translational approach for the treatment of COVID-19 disease: an updated overview

E Serretiello, A Ballini, A Smimmo, M Acunzo, M Raimo… - Viruses, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic
in the years 2020–2022. With a high prevalence, an easy route of transmission, and a long …

[HTML][HTML] Mesenchymal stem cells and MSCs-derived extracellular vesicles in infectious diseases: From basic research to clinical practice

N Yudintceva, N Mikhailova, V Fedorov… - Bioengineering, 2022 - mdpi.com
Mesenchymal stem cells (MSCs) are attractive in various fields of regenerative medicine due
to their therapeutic potential and complex unique properties. Basic stem cell research and …

[HTML][HTML] Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application

Y Zhao, Z Yan, Y Liu, Y Zhang, J Shi, J Li… - Stem cell research & …, 2021 - Springer
Pulmonary fibrosis (PF) is a chronic, progressive, fibrotic interstitial disease of the lung with
poor prognosis and without effective treatment currently. Data from previous coronavirus …